nifty CE OF 18100 of 25 May.
195
To
207.50
First Target Achieved
🍎🍎🍎🍎🍎🍎🚀🚀🚀🎉🎉🎉
195
To
207.50
First Target Achieved
🍎🍎🍎🍎🍎🍎🚀🚀🚀🎉🎉🎉
nifty CE OF 18100 of 25 May.
195
To
210.40
🍎🍎🍎🍎🍎🚀🚀🚀🎉🎉🎉
195
To
210.40
🍎🍎🍎🍎🍎🚀🚀🚀🎉🎉🎉
DK Technical Analysis by Dhananjay Kadam
Risky call Buy nifty CE OF 18100 of 25 May. NEAR 195 SL 185 TGT 207-214-219-227-230++
nifty CE OF 18100 of 25 May.
195
To
213.65😍
Almost second Target achieved 😍
🍎🍎🍎🍎🍎🚀🚀🚀🎉🎉🎉
195
To
213.65😍
Almost second Target achieved 😍
🍎🍎🍎🍎🍎🚀🚀🚀🎉🎉🎉
DK Technical Analysis by Dhananjay Kadam
Risky call Buy nifty CE OF 18100 of 25 May. NEAR 195 SL 185 TGT 207-214-219-227-230++
nifty CE OF 18100 of 25 May.
195
To
225😍😘😘😘
Almost 4th Target achieved 😍
🍎🍎🍎🍎🍎🚀🚀🚀🎉🎉🎉
195
To
225😍😘😘😘
Almost 4th Target achieved 😍
🍎🍎🍎🍎🍎🚀🚀🚀🎉🎉🎉
FACT - SL hits
if today it will be in gree then hold
Otherwise EXIT
if today it will be in gree then hold
Otherwise EXIT
*fund Houses Recommendations*
JP Morgan on *Reliance:* Maintain Overweight on company, target price at Rs 2960/sh (Positive)
MS on *Sun Pharma:* Maintain Overweight on company, target price at Rs 1170/sh (Positive)
Macquarie on *Mankind Pharma:* Initiate Outperform on company, target price at Rs 1400/sh (Positive)
Jefferies on India Strategy: The India's capex cycle will not be impacted by the global slowdown (Positive)
Morgan Stanley on India Strategy: Revenue and net profit growth of 12% and 13% YoY (Neutral)
JP Morgan on *Exide:* Maintain Overweight on company, target price at Rs 225/sh (Neutral)
Citi on *Exide:* Maintain Buy on company, target price at Rs 240/sh (Neutral)
Jefferies on *UPL:* Maintain Buy on company, target price at Rs 925/sh (Neutral)
Macquarie on *MGL:* Maintain Neutral on company, target price at Rs 925/sh (Neutral)
Jefferies on *MGL:* Maintain Hold on company, target price at Rs 1100/sh (Neutral)
Macquarie on *Pidilite:* Maintain Underperform on company, target price at Rs 2000/sh (Neutral)
MS on *Kansai:* Maintain Underweight on company, target price at Rs 322/sh (Neutral)
MS on *AB Fashion:* Maintain Underweight on company, target price at Rs 195/sh (Neutral)
Kotak on *UPL:* Maintain Reduce on company, cut target to Rs 690/sh (Negative)
JP Morgan on *Reliance:* Maintain Overweight on company, target price at Rs 2960/sh (Positive)
MS on *Sun Pharma:* Maintain Overweight on company, target price at Rs 1170/sh (Positive)
Macquarie on *Mankind Pharma:* Initiate Outperform on company, target price at Rs 1400/sh (Positive)
Jefferies on India Strategy: The India's capex cycle will not be impacted by the global slowdown (Positive)
Morgan Stanley on India Strategy: Revenue and net profit growth of 12% and 13% YoY (Neutral)
JP Morgan on *Exide:* Maintain Overweight on company, target price at Rs 225/sh (Neutral)
Citi on *Exide:* Maintain Buy on company, target price at Rs 240/sh (Neutral)
Jefferies on *UPL:* Maintain Buy on company, target price at Rs 925/sh (Neutral)
Macquarie on *MGL:* Maintain Neutral on company, target price at Rs 925/sh (Neutral)
Jefferies on *MGL:* Maintain Hold on company, target price at Rs 1100/sh (Neutral)
Macquarie on *Pidilite:* Maintain Underperform on company, target price at Rs 2000/sh (Neutral)
MS on *Kansai:* Maintain Underweight on company, target price at Rs 322/sh (Neutral)
MS on *AB Fashion:* Maintain Underweight on company, target price at Rs 195/sh (Neutral)
Kotak on *UPL:* Maintain Reduce on company, cut target to Rs 690/sh (Negative)